Search
for
Sort by
Research 241–270 of 1000+
- Cutaneous signs in COVID ‐19 patients: A review
- Novel adenosine triphosphate (ATP)-binding cassette, subfamily A, member 12 (ABCA12) mutations associated with congenital ichthyosiform erythroderma
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Pharmacology of anabolic steroids
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- COVID-19 Severity and Androgen Receptor Polymorphism
- Obesity and female androgenic alopecia: A cause and an effect?
- Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- MECHANISM OF ACTION OF AVICENNIA MARINA HEARTWOOD EXTRACT AND AVICEQUINONE C ON HUMAN DERMAL PAPILLA CELLS ISOLATED FROM ANDROGENIC ALOPECIA PATIENTS
- Hormonal therapies for acne
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- An Update of Congenital Adrenal Hyperplasia
- Androgen receptors and their biology
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- Cardiometabolic profile of young women with hypoprolactinemia
- Changes of androgens levels in menopausal women
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Therapeutic Androgen Receptor Ligands
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Nails and hair
- Is Prenatal Sex Hormone Balance a Risk Factor for the Development of Hidradenitis Suppurativa
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease